Literature DB >> 19571697

Pelvic exenteration with en bloc iliac vessel resection for lateral pelvic wall involvement.

Kirk K S Austin1, Michael J Solomon.   

Abstract

PURPOSE: Lateral pelvic recurrence is considered a poor prognostic variable and a relative contraindication to surgery because of the difficulty in achieving clear margins. The aim of this study was to outline our surgical approach to lateral pelvic sidewall involvement and assess the oncologic and long-term outcomes.
METHODS: A retrospective review of a prospective database was performed. Patient demographics, cancer and operative details, intent, margins, lymph node status, rerecurrence at resection site, follow-up, living and death details were assessed.
RESULTS: En bloc lateral pelvic wall dissection and vascular resection with pelvic exenteration was performed in 36 patients of 107 exenterations. All patients underwent surgery with curative intent. Negative margins were achieved in 19 patients (53%). Ten patients (28%) developed recurrence at the site of resection compared with 26 patients (72%) who remained disease free at the site of surgery. Sixteen patients (46%) are disease-free with the average disease-free interval of 30 months. Twenty-five patients (69%) are alive with a mean follow-up of 19 months. No mortalities occurred in this cohort of patients.
CONCLUSION: Despite the complexity of this technique, it is safe and feasible. Careful preoperative radiologic assessment and a multidisciplinary approach are paramount to achieving clear margins.

Entities:  

Mesh:

Year:  2009        PMID: 19571697     DOI: 10.1007/DCR.0b013e3181a73f48

Source DB:  PubMed          Journal:  Dis Colon Rectum        ISSN: 0012-3706            Impact factor:   4.585


  26 in total

Review 1.  Surgery for recurrent rectal cancer: technical notes and management of complications.

Authors:  A H Mirnezami; P M Sagar
Journal:  Tech Coloproctol       Date:  2010-05-12       Impact factor: 3.781

2.  Factors associated with the location of local rectal cancer recurrence and predictors of survival.

Authors:  Peng Du; John P Burke; Wisam Khoury; Ian C Lavery; Ravi P Kiran; Feza H Remzi; David W Dietz
Journal:  Int J Colorectal Dis       Date:  2016-02-10       Impact factor: 2.571

3.  Preoperative body mass index, 30-day postoperative morbidity, length of stay and quality of life in patients undergoing pelvic exenteration surgery for recurrent and locally-advanced rectal cancer.

Authors:  Jessica Beaton; Sharon Carey; Michael J Solomon; Ker-Kan Tan; Jane Young
Journal:  Ann Coloproctol       Date:  2014-04-25

4.  R0 resection, not surgical technique, is the key consideration in pelvic exenteration surgery.

Authors:  O J Warren; M J Solomon
Journal:  Tech Coloproctol       Date:  2014-12-28       Impact factor: 3.781

5.  Posterior high sacral segmental disconnection prior to anterior en bloc exenteration for recurrent rectal cancer.

Authors:  K G M Brown; M J Solomon; K K S Austin; P J Lee; P Stalley
Journal:  Tech Coloproctol       Date:  2016-03-21       Impact factor: 3.781

Review 6.  Locally Advanced Disease and Pelvic Exenterations.

Authors:  Christos Kontovounisios; Paris Tekkis
Journal:  Clin Colon Rectal Surg       Date:  2017-12-01

7.  [Resection of recurrent rectal cancer].

Authors:  I Gockel; C Pommer; S Langer; B Jansen-Winkeln
Journal:  Chirurg       Date:  2018-08       Impact factor: 0.955

8.  Outcome and prognostic factors of local recurrent rectal cancer: a pooled analysis of 150 patients.

Authors:  F Selvaggi; C Fucini; G Pellino; G Sciaudone; I Maretto; I Mondi; N Bartolini; F Caminati; S Pucciarelli
Journal:  Tech Coloproctol       Date:  2014-11-11       Impact factor: 3.781

9.  Extended lateral pelvic sidewall excision (ELSiE): an approach to optimize complete resection rates in locally advanced or recurrent anorectal cancer involving the pelvic sidewall.

Authors:  I Shaikh; W Aston; G Hellawell; D Ross; S Littler; D Burling; M Marshall; J M A Northover; A Antoniou; J T Jenkins
Journal:  Tech Coloproctol       Date:  2014-11-08       Impact factor: 3.781

10.  State-of-the-art surgery for recurrent and locally advanced rectal cancers.

Authors:  Mufaddal Kazi; Vivek Sukumar; Ashwin Desouza; Avanish Saklani
Journal:  Langenbecks Arch Surg       Date:  2021-08-02       Impact factor: 3.445

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.